Indian Medical Association demands explanation from Union Health Minister for 'promoting' Patanjali's untested Coronil
WHO's South-East Asia office clarified that it hadn't reviewed or certified the effectiveness of any traditional medicine for treating COVID-19.
2020, the year of conspiracy theories: As COVID-19 gripped the world, so did the desire for easy answers
Conspiracy theories offer simple, understandable explanations of events and help us regain a belief in human control over situations.
The CSE had published a study on Wedesday, saying honey sold by several major brands, including Dabur, Patanjali and Emami has been found adulterated with sugar syrup
The Centre for Science and Environment food researchers selected 13 top brands such as Dabur, Patanjali, Baidyanath, Zandu who sell raw honey, to check their purity
The new IPL title sponsor to replace Chinese mobile phone company Vivo will hold the rights for only a four-and-a-half-month period and the highest bid may not necessarily end up being the winning one, the BCCI stated on Monday.
The slot of the title sponsorship of IPL was vacated after the Chinese handset maker Vivo decided to exit from it.
Centre prohibits Patanjali from selling 'Coronil' as cure for COVID-19, instructs company to market it as immunity booster
At a press conference in Haridwar, Ramdev claimed the ministry has said that Patanjali did an an appropriate job for COVID-19 management.
Rajasthan Police lodges FIR against Ramdev, four others, for launching 'Coronil' without AYUSH ministry's approval
After the launch of the drug 'Coronil', the AYUSH ministry asked Patanjali Ayurved to provide details on the research leading up to it and its composition, telling the company to stop advertising it till the issue is examined.
Ramdev and the Coronil claim: Patanjali treading on thin legal ice, but enforcement gaps might let yoga guru get away with COVID 'drug'
Patanjali Ayurved is treading on thin legal ice with regard to the true effect of the drug compared to what is claimed. Considering the widespread adverse impact that could result from reliance upon an ineffective drug during a deadly pandemic, the question also arises as to whether the usual standard of approval of new drugs is sufficient for the present situation or whether a different standard has to be adopted despite the urgent need for a remedy.
Patanjali has submitted report on 'ayurvedic COVID-19 medicine', decision will be taken soon, says Centre
The Ayush minister said that the ministry will look into Patanjali's report and then decide about giving final permission to the company over the medicine.
Stop advertising claims of 'Ayurvedic COVID-19 medicine' until verification, Ayush ministry tells Ramdev's Patanjali Ayurveda
Earlier on Tuesday, Patanjali founder Ramdev said that the medicines, 'Coronil and Swasari', "were developed based on research and trials on 280 patients across the country," NDTV reported.
Patanjali CEO Acharya Balkrishna claims company has developed Ayurvedic medicine to cure COVID-19 patients
Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali on Saturday claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 5-14 days
Baba Ramdev-led Patanjali Ayurved's Rs 250 crore debentures issue got fully subscribed within three minutes of opening on Thursday
Fair trade regulator CCI on Thursday dismissed a complaint alleging abuse of dominant position by SBI and collusion with Patanjali Ayurveda and International Traders in a bidding process
Senior Congress leader P Chidambaram on Wednesday asked the government why it had taken the technical loan write-off route for fugitives like Nirav Modi, Mehul Choksi and Vijay Mallya
Wilful defaulters beneficiaries of 'phone banking' under UPA regime, Modi govt chasing them to recover dues: Nirmala Sitharaman
Hitting out at the Congress party, Finance Minister Nirmala Sitharaman has said that wilful defaulters were beneficiaries of 'phone banking' under the UPA regime and the Modi government is chasing them to recover the dues
Over Rs 68,600 cr loans of wilful defaulters written off; Mehul Choksi, Vijay Mallya's firms among list: RBI in RTI reply
Outstanding loans amounting to Rs 68,607 crore of top 50 wilful bank loan defaulters in the country including firms of Mehul Choksi and Vijay Mallya have been technically written off till 30 September, 2019, the Reserve Bank of India said in a RTI reply
Coronavirus Outbreak: Nivea India starts manufacturing hand sanitisers; to be distributed free of cost
The hand sanitisers will be distributed free of cost to the public hospitals and healthcare institutions in Ahmedabad and Vadodara as well as to distribution partners across the country.
ICAR said it will assist PBRI in technology demonstration, capacity building, seed production for scaling up popular varieties developed by ICAR
Patanjali completes acquisition of Ruchi Soya, Dhanuka Agritech revenue up; all this and more on Moneycontrol Pro
Baba Ramdev’s Patanjali group has completed its acquisition of Ruchi Soya via the corporate insolvency process.